Clinical trials of first TB vaccine from human source begins in India “We are delighted to join forces with Bharat Biotech to reinforce the global supply of polio vaccines. Our vision is to ...

Commenting on the development, SII CEO Adar Poonawalla said “We are delighted to join forces with Bharat Biotech to reinforce the global supply of polio vaccines. Our vision is to eradicate ...

HYDERABAD: Biovet, an arm of Bharat Biotech group that makes animal health vaccines, has received a licence from the Central Drug Standards Control Organisation (CDSCO) for its lumpy skin disease ...

Hyderabad: Vaccine maker Bharat Biotech invested Rs 1,500 crore in setting ... world's first licensed malaria vaccine RTS,S, and the oral polio vaccine. "In the future, the facility will also ...

Animal health vaccine maker and Bharat Biotech group firm Biovet on Monday (February 10, 2025) said it has received the Central Drug Standards Control Organization (CDSCO) licence for the lumpy ...

Bharat Biotech group company Biovet, an innovative animal health vaccine producer based in Mallur, Karnataka, has announced that its lumpy skin disease (LSD) vaccine for dairy cattle and buffaloes, ...

Biovet, a Bharat Biotech group company, has received a licence from the Central Drugs Standard Control Organization (CDSCO) for its lumpy skin disease (LSD) vaccine for dairy cattle. The firm has ...

The vaccine got approval by the central drugs standard organisation (CDSCO). (Bharat Biotech | Official X account) Over the past two years, approximately 200,000 cattle have died, and millions ...

Bharat Biotech, Bilthoven Biologicals collaborate for oral polio vaccines production, supply Through this collaboration, Bharat Biotech and Bilthoven Biologicals (BBio) will jointly obtain ...

New Delhi, Bharat Biotech has claimed that amongst all the vaccine platforms such as an mRNA-based vaccine, DNA-based vaccine, vector-based vaccine, or live attenuated vaccines, etc., the ...

Bharat Biotech group company, Biovet, has received approval from the national drugs regulator to market a vaccine against lumpy skin disease (LSD) in dairy cattle and buffaloes, the company ...

This vaccine offers a high safety and efficacy profile while enabling serological differentiation between naturally infected and vaccinated animals with the DIVA concept in it.